Risk / Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988 - Developments in Cardiovascular Medicine - J Morganroth - Books - Springer-Verlag New York Inc. - 9781461288886 - October 10, 2011
In case cover and title do not match, the title is correct

Risk / Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988 - Developments in Cardiovascular Medicine Softcover reprint of the original 1st ed. 1989 edition

Price
$ 205.49
excl. VAT

Ordered from remote warehouse

Expected to be ready for shipping Jul 14 - 20
Add to your iMusic wish list

Not rated yet

The Ninth Annual symposium on New Drugs addressed the problem of determining the risk versus benefit for use of three important classes of cardiovascular agents: thrombolytic, antiarrhythmic, and hypolipidemic agents.


298 pages, biography

Media Books     Paperback Book   (Book with soft cover and glued back)
Released October 10, 2011
ISBN13 9781461288886
Publishers Springer-Verlag New York Inc.
Pages 298
Dimensions 234 × 154 × 23 mm   ·   490 g
Language English  
Editor Moore, E. Neil
Editor Morganroth, J.

More by J Morganroth

Show all

Mere med samme udgiver